Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
Go back to Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD| (NASDAQ: AIFF) | Delayed: 1.05 -0.01 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.06 | 52 Week High | $ | |||
| Open | $1.07 | 52 Week Low | $ | |||
| Day High | $1.09 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $ | |||
| Volume | 47,539 | |||||



